Nexplanon recommended after second submission

22 October 2020 - The first submission was withdrawn. ...

Read more →

Will HIRA resume talk to grant benefits for anti-diabetic combo drugs?

22 October 2020 - Three makers of SGLT-2 inhibiting anti-diabetic drugs said they would seek changes in approval conditions to ...

Read more →

CADTH in favour of new indication for Soliris

22 October 2020 - CADTH has finalised its assessment of eculizumab for adult patients with refractory generalised myasthenia gravis. ...

Read more →

NICE in favour of another highly specialised technology

21 October 2020 - Familial chylomicronaemia syndrome is a rare and potentially life-threatening condition that has a significant effect on the ...

Read more →

ICER posts draft scoping document for the assessment of Alzheimer’s disease

21 October 2020 - Document open to public comment until 10 November 2020. ...

Read more →

NICE recommended use of Opdivo for another indication

20 October 2020 - This marks the tenth NICE recommendation for nivolumab. ...

Read more →

California plans to review coronavirus vaccine independently

19 October 2020 - California is planning to review federally approved coronavirus vaccines independently before distributing it to residents, Governor ...

Read more →

Welcome to the new PHARMAC.govt.nz

20 October 2020 - PHARMAC has upgraded the technology underlying its website. ...

Read more →

PBAC recommends Zeposia for patients with relapsing-remitting multiple sclerosis

16 October 2020 - Did Celgene really request its use for the treatment of non-premenopausal patients with hormone receptor positive, ...

Read more →

Highlights from 12-15 October CHMP meeting

16 October 2020 - Ten new medicines recommended for approval. ...

Read more →

ICER publishes final report and policy recommendations for targeted immune modulator therapies for ulcerative colitis

16 October 2020 - Independent appraisal committee votes that evidence is adequate to demonstrate clinical superiority of vedolizumab over adalimumab. ...

Read more →

Community engagement in health technology assessment and beyond: from guests in the process to hosts

15 October 2020 - In health technology assessment, clinical and economic evidence are assessed in the regulatory and reimbursement environments, with ...

Read more →

ICER publishes evidence report on therapies for haemophilia A

16 October 2020 - Emicizumab assessed as providing comparable or better clinical benefits when compared to common current dosing levels of ...

Read more →

NICE gears up to support world evidence-based health care day

16 October 2020 - Inaugural World Evidence-based Health care Day takes place on Tuesday 20 October 2020. ...

Read more →

Recommendations made by the PBAC - September 2020 intracycle meeting and out of session between July 2020 and September 2020 meetings

16 October 2020 - The recommendations from the September 2020 PBAC intracycle meeting are now available. ...

Read more →